HIGHLIGHTS
- who: Report and colleagues from the (UNIVERSITY) have published the article: Review began 08/05/2022 Review ended 08/11/2022 Published 08/19/2022 u00a9 Copyright, in the Journal: (JOURNAL) of August/19,/2022
- what: This case reflects the importance of performing molecular screening as a means to identify new therapeutic targets.
- future: Studies are needed to clarify subsequent treatment in the case of progression and to recognize the mechanisms of resistance that may arise.
SUMMARY
Gliomas and glioneuronal tumours are the most prevalent group of intrinsic central . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.